IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 336 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 1.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $231,000 | -20.9% | 5,156 | 0.0% | 0.00% | – |
Q4 2020 | $292,000 | +15.9% | 5,156 | 0.0% | 0.00% | – |
Q3 2020 | $252,000 | -58.7% | 5,156 | -50.0% | 0.00% | -100.0% |
Q2 2020 | $610,000 | +147.0% | 10,312 | +100.0% | 0.00% | 0.0% |
Q1 2020 | $247,000 | -20.6% | 5,156 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $311,000 | +0.6% | 5,156 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $309,000 | -6.9% | 5,156 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $332,000 | -95.9% | 5,156 | -94.8% | 0.00% | -94.1% |
Q1 2019 | $8,053,000 | -51.5% | 99,188 | -67.7% | 0.02% | +21.4% |
Q4 2018 | $16,596,000 | +51.8% | 306,930 | +44.8% | 0.01% | +16.7% |
Q3 2018 | $10,932,000 | +289.7% | 211,954 | +214.9% | 0.01% | +71.4% |
Q2 2018 | $2,805,000 | +6.5% | 67,314 | +12.6% | 0.01% | +16.7% |
Q1 2018 | $2,634,000 | +2482.4% | 59,760 | +1275.1% | 0.01% | – |
Q2 2016 | $102,000 | +15.9% | 4,346 | +100.0% | 0.00% | – |
Q1 2016 | $88,000 | -20.7% | 2,173 | +20.7% | 0.00% | – |
Q4 2015 | $111,000 | – | 1,800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BB BIOTECH AG | 6,529,838 | $404,393,000 | 11.39% |
DOWLING & YAHNKE LLC | 676,379 | $41,888,000 | 5.27% |
Opus Point Partners Management, LLC | 102,459 | $6,345,000 | 4.19% |
WILLIAM HARRIS INVESTORS INC | 230,443 | $14,271,000 | 3.43% |
PINNACLE ASSOCIATES LTD | 1,690,263 | $104,678,000 | 2.20% |
MESSNER & SMITH THEME VALUE INVESTMENT MANAGEMENT LTD /CA/ | 21,298 | $1,319,000 | 2.11% |
Sonora Investment Management, LLC | 126,763 | $7,850,000 | 2.04% |
Virtus ETF Advisers LLC | 10,447 | $647,000 | 1.78% |
Apex Capital Management | 1,020,096 | $63,175,000 | 1.41% |
PERKINS CAPITAL MANAGEMENT INC | 19,900 | $1,232,000 | 1.32% |